Serologic measurements for peanut allergy: Predicting clinical severity is complex.

Area of Science:

• Allergy and Immunology
• Diagnostic Testing
• Peanut Allergy Research

Background:

• Allergist-immunologists utilize serologic testing for peanut allergy diagnosis, seeking to optimize sensitivity, specificity, cost, and convenience.
• Recent advancements include improved understanding of specific IgE (sIgE), component testing, epitope-sIgE assays, and basophil activation testing.

Purpose of the Study:

• To review current and emerging serologic testing methods for peanut allergy.
• To discuss the challenges and limitations in predicting reaction severity using serologic tests.
• To emphasize the importance of shared decision-making in allergy test selection.

Main Methods:

• Review of recent advances in serologic peanut allergy testing.
• Evaluation of specific IgE (sIgE), component testing, epitope-sIgE assays, and basophil activation testing.
• Consideration of factors influencing reaction severity and test limitations.

Main Results:

• Ara h 2-sIgE testing is recommended as a cost-effective diagnostic for peanut allergy.
• Basophil activation testing shows promise for diagnosis and prognosis.
• Epitope-sIgE testing may enhance prediction of reaction thresholds, requiring further validation.
• Cost, accessibility, and feasibility remain limitations for many advanced tests.

Conclusions:

• Advances in serologic testing improve peanut allergy diagnosis and prognosis.
• Predicting reaction severity is complex due to co-factors and requires further research, particularly regarding atopic dermatitis.
• Shared decision-making is essential for personalized allergy test selection, balancing patient preferences with clinical expertise.